SEC Form 4 · accession 0001562180-16-003160
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victor Sandor
Officer — Chief Medical Officer
Period of report
Sep 22, 2016
Accepted (ET)
Sep 23, 2016 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 22, 2016 | M | 95,890 | $3.69 | A | 200,733 | D | |
| Common StockF3 | Sep 22, 2016 | F | 31,117 | $3.69 | D | 169,616 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | Sep 22, 2016 | M | 95,890 | D | — | Sep 22, 2016 | Common Stock | 95,890 | 0 | D |
Explanation of responses
- F1Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on September 22, 2014 as a result of the vesting of one half of such RSUs.
- F2Includes 23,438 RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma, Inc. common stock. The units vest and will be settled in stock in four equal annual installments beginning on April 1, 2016.
- F3Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- F4RSUs were awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock.
- F5The RSUs vest in two equal annual installments beginning September 22, 2015.